Two US labor unions drop out of Obama reform plan

23 March 2009

Two US labor unions, the American Federation of State, County and Municipal Employees and the Service Employees International Union, have  backed out of a coalition of groups supporting President Barack Obama's  health care reforms, which are supported by the Pharmaceutical Research  and Manufacturers of America (PhRMA; Marketletters passim).

Lori Lodes, a spokeswoman for the SEIU said: "we strongly support the  health care proposal Pres Obama laid out in the [election] campaign."  This, she claimed, included a public insurance option and the obligation  that all businesses would be require, by law, to pay for at least part  of the health care insurance of their employees.

However, such a policy would be enormously expensive for smaller firms  and would be firmly opposed by insurers. Even with barely enough votes  to hold up legislation in the Senate, the Republican opposition is  likely to try to block what critics argue would be a publicly-subsidized  competitor to private and non-profit insurance providers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight